About Tomocube
Tomocube is a publicly listed company based in Daejeon (South Korea) founded in 2015. Holographic microtomography is utilized for live cell imaging in microscopy. Tomocube has raised $2 million across 1 funding round from investors including SBVA. The company has 65 employees. Its website tomocube.com draws about 10 thousand monthly visits. Its focus areas include Life Sciences, Imaging Diagnostics, Microscopy and Life Sciences Platforms and Tools. Its legal entity is Tomocube Co., Ltd.
Company details
Tomocube was founded in 2015 in Daejeon, South Korea, and operates within the cellular microscopy sector. The Tomocell HT-1, a high-speed microscope, is produced to enable non-invasive, real-time analysis of live cells via holographic microtomography. Quantitative data on cell volume, sub-cellular organelle shapes, cytoplasmic density, surface area, and deformability are delivered at high resolutions. Applications span research and medical diagnostics.
- Headquarters Daejeon, South Korea
- Employees 65
- Stage Public
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website tomocube.com
- Social LinkedIn X Facebook YouTube
- Legal Name Tomocube, Inc.
- Annual Revenue$7.83 M (USD)90.39as on Dec 31, 2025
- Net Profit-$3.33 M (USD)42.06as on Dec 31, 2025
- EBITDA-$2.81 M (USD)46.27as on Dec 31, 2025
- Total Equity Funding$2M (USD)
in 1 rounds
- Latest Funding Round$2M (USD), Series A
Apr 2016
- Investors
- Employee Count65
Apps and channels of Tomocube
its YouTube channel Tomocube Inc. has 1.67K subscribers and 30 videos.
Videos from Tomocube
The most watched videos on Tomocube's YouTube channel, Tomocube Inc. (1.67K subscribers). Click a video to play it here.
More on Tomocube Inc..
Funding Insights of Tomocube
Tomocube has successfully raised a total of $2M through 1 strategic funding round. The most recent funding activity was a Series A round of $2 million completed in April 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2M
- Total Rounds 1
- Last Round Series A β $2M
- First Round $2M
(Apr 2016)
- Investors Count 1
All 1 funding rounds of Tomocube with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2016 | $2M | Series A | β | β |
1 investors in total: 1 institutional.
Investors in Tomocube
Tomocube has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SBVA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital arm of SoftBank Group | sbvacorp.com | Seoul, South Korea |
Investor details for Tomocube
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Tomocube
9 people are tracked at Tomocube (4 in leadership, 5 in team); the tracked headcount is 65.
| Name | Role | Group |
|---|---|---|
Mike G. Crump | Sales Director | Leadership |
YongKeun Park | CEO | Leadership |
Sungho Ko | COO | Leadership |
Kyungtae Oh | CFO | Leadership |
Daniel Ghete | EMEA Applications Manager | Team |
Justine Wang | Administrative Assistant | Team |
Brian Templin | Regional Sales Manager | Team |
Taehong Kim | Vice Preaident Of Precision Division | Team |
Reza Pari-Nejad | Regional Sales Manager | Team |
Complete people profiles for Tomocube
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Tomocube
Tomocube is a publicly listed company on the KRX with ticker symbol 475960 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 Nov 2024
- Listed onKRX: 475960
- Listed entityTOMOCUBE, Inc.
- Exchange sectorHealth technology
- ISINKR7475960001
- Share price31,200.00 KRW (-0.16% on the day) · 2026-10-14
- Market capitalisation421,130,418,777.00 KRW
- EPS (diluted, trailing year)-184.29 KRW
- Volume (last session)30,613
Financials of Tomocube
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 11.31B KRW | -4.81B KRW | -4.06B KRW |
| 2024 | 5.94B KRW | -8.30B KRW | -7.55B KRW |
| 2023 | 3.75B KRW | -23.55B KRW | -5.61B KRW |
| 2022 | 1.87B KRW | 29.34B KRW | -5.65B KRW |
| 2021 | 1.63B KRW | -19.35B KRW | -5.81B KRW |
Detailed financial statements for Tomocube
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Tomocube
3 dated milestones of Tomocube across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Tomocube is founded.
- Funding First funding round of $2.0M.
- IPO Lists on the stock exchange (IPO).
Web traffic of Tomocube
The website of Tomocube (tomocube.com) receives about 10.2K visits a month.
- Monthly visits10.2K
▼ 14.6% vs previous month
Websites whose visitors overlap most with Tomocube. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
kontrs.or.kr | kontrs.or.kr | 100% | #1,574,180 | β | |
hellodd.com | hellodd.com | 61% | #174,837 | β |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tomocube
Complete news archive for Tomocube
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tomocube
Tomocube was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Tomocube is headquartered in Daejeon, South Korea.
Tomocube is a funded company, having raised a total of $2M across 1 funding round to date. The company's 1st funding round was a Series A of $2M, raised on Apr 2016.
Tomocube has 65 employees.
Annual revenue of Tomocube is $7.83M as on Dec 31, 2025.
Tomocube was founded in 2015 in Daejeon, South Korea, and operates within the cellular microscopy sector. The Tomocell HT-1, a high-speed microscope, is produced to enable non-invasive, real-time analysis of live cells via holographic microtomography. Quantitative data on cell volume, sub-cellular organelle shapes, cytoplasmic density, surface area, and deformability are delivered at high resolutions. Applications span research and medical diagnostics.
Yes, Tomocube is publicly traded on KRX under the ticker symbol 475960.
Tomocube has 1 investor. Key investors include SBVA.
Tomocube operates through Tomocube Co., Ltd..